NEW YORK, March 30, 2022 (GLOBE NEWSWIRE) -- The global freeze and thaw systems market was valued at US$ 318.9 Mn in 2021. Transport Adapté
Significant rise in incidence of chronic illnesses and increasing research development activities with collaborative efforts by manufacturers for the introduction of novel therapeutics are driving market expansion. The market is expected to exhibit a CAGR of 6.8% over the forecast period (2022-2032).

Demand for novel and alternate therapeutics and growing product development associated with global metrics on disease burden have propelled demand for freeze and thaw systems, globally. Developed economies of North America and Europe are experiencing a shift toward single-use equipment and tools, and have thus enhanced their production and transport capabilities within their regions and also worldwide.

Adoption of freeze and thaw systems in the biotechnology and pharmaceutical sphere has promoted greater industrial efficiency in terms of throughput and output. Large-scale manufacturing processes require vigilant monitoring around the manufacturing cycle, and ensuring product viability is a critical element. Freeze and thaw systems provide quicker application of use and promote easy application for further processes.
Persistence Market Research offers a unique perspective and actionable insights on the freeze and thaw systems market in its latest study, presenting historical demand assessment of 2017 – 2021 and projections for 2022 – 2032.

The research study is based on the product (freeze-thaw modular platforms (lab scale, small/pilot scale, and large scale), controlled rate chambers, single-use bags, and shippers), application (RD, pre-clinical clinical, and commercial), and end user (academic research institutes, pharmaceutical biotechnology companies, contract research organizations, and contract manufacturing organizations), across seven key regions of the world.